Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population.

Abstract

UNLABELLED Multiple Sclerosis (MS) is a central nervous system (CNS) chronic inflammatory demyelinating disease leading to various neurological disabilities. The disorder is more prevalent for women with a ratio of 3:2 female to male. OBJECTIVES To investigate variation within the estrogen receptor 1 (ESR1) polymorphism gene in an Australian MS case-control population using two intragenic restriction fragment length polymorphisms; the G594A located in exon 8 detected with the BtgI restriction enzyme and T938C located in intron 1, detected with PvuII. One hundred and ten Australian MS patients were studied, with patients classified clinically as Relapsing Remitting MS (RR-MS), Secondary Progressive MS (SP-MS) or Primary Progressive MS (PP-MS). Also, 110 age, sex and ethnicity matched controls were investigated as a comparative group. No significant difference in the allelic distribution frequency was found between the case and control groups for the ESR1 PvuII (P = 0.50) and Btg1 (P = 0.45) marker. Our results do not support a role for these two ESR1 markers in multiple sclerosis susceptibility, however other markers within ESR1 should not be excluded for potential involvement in the disorder.

Extracted Key Phrases

2 Figures and Tables

Cite this paper

@article{Tajouri2007AllelicVI, title={Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population.}, author={Lotti Tajouri and Francesca Fernandez and Sophie Ines Tajouri and Geraldine Detriche and Attila L. Szvetko and Natalie J. Colson and Peter A. Csurhes and Michael P. Pender and Lyn R Griffiths}, journal={Journal of the neurological sciences}, year={2007}, volume={252 1}, pages={9-12} }